[18] FDA identified limitations in characterization data, potential immunogenicity concerns for injectable use, limited information for proposed routes, lack of established effectiveness for obesity, and insufficient long-term safety information
In contrast, the bulkier Y37 rAmy in rAmy-bound AMY 2 R prevents equivalent interactions of N35 rAmy with RAMP2, and instead the bulkier Y37 rAmy forms interactions with E101 RAMP2 and F111 RAMP2 stabilising the peptide at the CTR/RAMP ECD interface in the bypass conformation
Enhanced intracellular reactive oxygen species by photodynamic therapy effectively promotes chemoresistant cell death
Pu J, Wang Q, Xu W, Lu L, Jiang S
Researchers who need to vary the ratio in their protocols may prefer individual vials, while those using a fixed 1:1 ratio benefit from the BPC-157 TB-500 blend format